The Hindu : Business : Ranbaxy pays 120 p.c. final

Online edition of India's National Newspaper
Saturday, Mar 29, 2008
ePaper | Mobile/PDA Version

Business

Business

Ranbaxy pays 120 p.c. final

Corporate Reporter

CHENNAI: The directors of Ranbaxy Laboratories have approved the payment of a final dividend of 120 per cent (Rs. 6 per share of Rs. 5 each) for the year ended December 31, 2007. In November last year, an interim dividend of 50 per cent (Rs. 2.50 per share) was paid. The total dividend for the year works out to 170 per cent or Rs. 8.50 per share.

The company has reported a consolidated sales of Rs. 6,692.70 crore for 2007, against Rs. 6,065.20 crore in the previous year, a growth of 10 per cent. The profit, before interest, depreciation and taxation has increased by 45 per cent to Rs. 1,358.10 crore from Rs. 939 crore. The profit after tax has risen by 53 per cent to Rs. 786.60 crore from Rs. 515.40 crore.

Global sales

Global sales on a consolidated basis rose by 21 per cent to $1619 million with emerging markets contributing 54 per cent of global sales.

The key emerging markets included India, CIS, Romania, South Africa and Brazil. Dosage form sales stood at $1515 million, contributing 94 per cent of global sales and recording a growth of 24 per cent.

Printer friendly page
Send this article to Friends by E-Mail

Business

News Update

Stories in this Section